pI: 4.4864 |
Length (AA): 196 |
MW (Da): 21791 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
32 | 76 | 2k7b (A) | 17 | 61 | 36.00 | 0.8 | 0.99 | 0.767092 | -0.9 |
34 | 196 | 5d43 (A) | 25 | 172 | 72.00 | 0 | 1 | 1.66453 | -1.29 |
34 | 196 | 3kf9 (A) | 21 | 168 | 77.00 | 0 | 1 | 1.69353 | -1.08 |
34 | 121 | 3ekj (A) | 307 | 379 | 55.00 | 0.0000007 | 1 | 1.00388 | -1.91 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128884)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G50360 | centrin2 |
Babesia bovis | BBOV_III003480 | EF hand domain containing protein |
Cryptosporidium hominis | Chro.30159 | centrin |
Cryptosporidium parvum | cgd3_1270 | centrin, putative |
Drosophila melanogaster | Dmel_CG17493 | CG17493 gene product from transcript CG17493-RB |
Echinococcus granulosus | EgrG_000843000 | centrin 2 |
Echinococcus granulosus | EgrG_000964800 | Centrin 1 |
Echinococcus granulosus | EgrG_000968500 | centrin 2 |
Echinococcus multilocularis | EmuJ_000964800 | Centrin 1 |
Echinococcus multilocularis | EmuJ_000968500 | centrin 2 |
Echinococcus multilocularis | EmuJ_000843000 | centrin 2 |
Giardia lamblia | GL50803_6744 | Centrin |
Homo sapiens | 1069 | centrin, EF-hand protein, 2 |
Homo sapiens | 1068 | centrin, EF-hand protein, 1 |
Leishmania braziliensis | LbrM.07.0780 | centrin, putative,caltractin, putative |
Leishmania donovani | LdBPK_070790.1 | centrin, putative |
Leishmania infantum | LinJ.07.0790 | centrin, putative,caltractin, putative |
Leishmania major | LmjF.07.0710 | centrin, putative,caltractin, putative |
Leishmania mexicana | LmxM.07.0710 | centrin, putative,caltractin, putative |
Mus musculus | ENSMUSG00000031347 | centrin 2 |
Mus musculus | 26369 | centrin 1 |
Neospora caninum | NCLIV_063750 | Calmodulin, related |
Oryza sativa | 4343922 | Os07g0618800 |
Plasmodium berghei | PBANKA_0206300 | centrin-1, putative |
Plasmodium falciparum | PF3D7_0107000 | centrin-1 |
Plasmodium knowlesi | PKNH_0206500 | centrin-1, putative |
Plasmodium vivax | PVX_081420 | centrin-1, putative |
Schistosoma japonicum | Sjp_0011490 | Centrin-1, putative |
Schistosoma mansoni | Smp_134950 | centrin-related |
Schmidtea mediterranea | mk4.004035.00 | Uncharacterized calcium-binding protein |
Schmidtea mediterranea | mk4.003529.04 | |
Schmidtea mediterranea | mk4.000308.09 | |
Schmidtea mediterranea | mk4.000114.07 | |
Schmidtea mediterranea | mk4.001420.01 | |
Trypanosoma brucei gambiense | Tbg972.8.645 | centrin, putative,caltractin, putative |
Trypanosoma brucei | Tb927.8.1080 | centrin, putative |
Trypanosoma congolense | TcIL3000_8_680 | centrin, putative |
Trypanosoma cruzi | TcCLB.503727.10 | centrin, putative |
Trypanosoma cruzi | TcCLB.506401.90 | centrin, putative |
Toxoplasma gondii | TGME49_247230 | centrin |
Theileria parva | TP03_0058 | centrin, putative |
Trichomonas vaginalis | TVAG_238650 | calmodulin, putative |
Trichomonas vaginalis | TVAG_311320 | calmodulin, putative |
Trichomonas vaginalis | TVAG_311330 | caltractin, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1080 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1080 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1080 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.1080 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0206300 | Plasmodium berghei | Essential | plasmo |
TGME49_247230 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.7
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Calmodulin | 149 aa | 47.1% | 157 aa | Compounds | References |
1 literature reference was collected for this gene.